0001209191-23-035256.txt : 20230607
0001209191-23-035256.hdr.sgml : 20230607
20230607212207
ACCESSION NUMBER: 0001209191-23-035256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230605
FILED AS OF DATE: 20230607
DATE AS OF CHANGE: 20230607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GAUGLER DARYL
CENTRAL INDEX KEY: 0001928278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35060
FILM NUMBER: 231000492
MAIL ADDRESS:
STREET 1: C/O PACIRA BIOSCIENCES, INC.
STREET 2: 5 SYLVAN WAY, SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacira BioSciences, Inc.
CENTRAL INDEX KEY: 0001396814
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510619477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5401 WEST KENNEDY BOULEVARD
STREET 2: SUITE 890
CITY: TAMPA
STATE: FL
ZIP: 33609
BUSINESS PHONE: 813-553-6680
MAIL ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Pacira Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20101029
FORMER COMPANY:
FORMER CONFORMED NAME: PACIRA INC
DATE OF NAME CHANGE: 20080318
FORMER COMPANY:
FORMER CONFORMED NAME: Blue Acquisition Corp
DATE OF NAME CHANGE: 20070418
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-05
0
0001396814
Pacira BioSciences, Inc.
PCRX
0001928278
GAUGLER DARYL
C/O PACIRA BIOSCIENCES
5401 WEST KENNEDY BOULEVARD, SUITE 890
TAMPA
FL
33609
0
1
0
0
Chief Operating Officer
1
Common Stock
2023-06-05
4
S
0
1000
38.74
D
23591
D
Common Stock
2023-06-06
4
S
0
1005
38.991
D
22586
D
Common Stock
2023-06-07
4
S
0
1047
37.865
D
21539
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
/s/ Kristen Williams, Attorney-in-Fact
2023-06-07